Suppr超能文献

[恶性肾上腺肿瘤的系统治疗]

[Systemic therapy of malignant adrenal tumors].

作者信息

Horstmann M, Merseburger A S, Stenzl A, Kuczyk M

机构信息

Klinik für Urologie, Eberhard-Karls-Universität, Tübingen, Germany.

出版信息

Urologe A. 2006 May;45(5):605-8. doi: 10.1007/s00120-006-1038-2.

Abstract

Systemic treatment of advanced-stage adrenal malignancies is most often only palliative. Mitotane alone or in combination with other chemotherapeutic agents such as cisplatin, etoposide, and vincristine are established therapeutic concepts for the treatment of metastatic adrenal cancer. Suramin and gossypol are rarely employed. New therapeutic options are tumor vaccination and treatment with antiangiogenic drugs. Metaiodobenzylguanidine as a radiotherapeutic drug or chemotherapeutic combination therapies that include cyclophosphamide, vincristine, and dacarbazine are applied for systemic treatment of malignant pheochromocytomas.. However, the clinical efficacy of the latter regimen needs further evaluation.

摘要

晚期肾上腺恶性肿瘤的全身治疗通常仅具有姑息作用。米托坦单独使用或与其他化疗药物(如顺铂、依托泊苷和长春新碱)联合使用是治疗转移性肾上腺癌的既定治疗理念。苏拉明和棉酚很少使用。新的治疗选择是肿瘤疫苗接种和抗血管生成药物治疗。间碘苄胍作为一种放射治疗药物或包括环磷酰胺、长春新碱和达卡巴嗪在内的化疗联合疗法被用于恶性嗜铬细胞瘤的全身治疗。然而,后一种方案的临床疗效需要进一步评估。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验